Deaconess and the Warrick County Health Department will host a new drive/walk-through testing site starting Friday, Nov. 20.
The new site will be hosted at 3199 State Road 261 in Newburgh near Castle High School. According to a release, the collaboration is the result of an Indiana State Department of Health grant, and will continue through June 2021 to be used for testing, as well as possible vaccine administration.
“As this pandemic continues, we know that testing and appropriate tracing/quarantining will continue to be a key component of reducing spread in our community,” said Aaron Franz, Warrick County Health Department executive director. “This collaboration with Deaconess will improve testing access for all Warrick County residents, and will help us further protect workers and students to help them feel safe in their workplaces and schools.”
Patients will be able to receive test results through the Deaconess MyChart app as soon as those results are available; patients without a MyChart account will also receive phone calls with positive results, but this process will not be as immediate as MyChart. Educational materials in both English and Spanish will be available at testing sites.
Those seeking testing will be able to schedule an appointment online at www.deaconess.com/testing. More information, including when testing is appropriate, is also included on the website.
The new site is opening as the Newburgh CVS joins other CVS locations in offering testing. While seven Evansville locations previously offered testing to customers, Newburgh is joining the effort with testing set to begin on Friday, Nov. 20.
“Access to rapid-result tests enables us to help minimize community spread of COVID-19 by being able to more quickly identify active COVID-19 infection,” said David Fairchild, MD, Chief Medical Officer, MinuteClinic. “In addition, we can test and treat symptomatic patients who test negative for COVID-19 for seasonal illnesses such as flu or strep and provide appropriate treatment and care.”
According to a release from CVS Health on Wednesday, Oct. 28, the pharmacy chain was set to add nearly 1,000 rapid-result test sites at locations across the country. The release states that rapid-result COVID-19 diagnostic tests are available at no cost to patients who meet Centers for Disease Control and Prevention criteria.
Patients must register in advance at CVS.com to schedule an appointment. Testing is also available for patients ages 12 to 17; a parent or legal guardian must complete the online registration and must accompany minors ages 15 and younger for testing.
According to the release, nearly 100 of the planned rapid-result test sites were set to be operational at select CVS Pharmacy locations in 22 states the week of the release. States include Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Massachusetts, Maryland, Michigan, Minnesota, Missouri, North Carolina, New Jersey, New Mexico, Ohio, Pennsylvania, Rhode Island, South Carolina, Texas, and Virginia.